Latest News

doctor patient biosimilar | Image credit: Prostock-studio -
Samsung Bioepis’ Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults

July 6th 2024

A phase 1 study demonstrated pharmacokinetic (PK) bioequivalence of the proposed ustekinumab biosimilar SB17 (Samsung Bioepis) to the EU- and US-sourced reference products.

fda approved | Image credit: Argus -
FDA Approves Samsung Bioepis’ Pyzchiva, a Biosimilar to Stelara

July 1st 2024

syringes for subcutaneous injection | Image credit: SOPONE -
Phase 3 Trials Find Subcutaneous Infliximab CT-P13 Superior to Placebo in IBD

June 29th 2024

UK healthcare and biosimilars | Image credit: millaf -
Biosimilar Adoption in the UK: Patient and Consultant Views on Safety and Switching

June 26th 2024

doctor filling biosimilar syringe| Image credit: PhotobyTawat
No Differences in Treatment Persistence, Safety Detected for Anti-TNF Biosimilars vs Originators

June 22nd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.